Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Oncology Letters
      • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Biomedical Reports
      • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • Information for Authors
    • Information for Reviewers
    • Information for Librarians
    • Information for Advertisers
    • Conferences
  • Language Editing
Spandidos Publications Logo
  • About
    • About Spandidos
    • Aims and Scopes
    • Abstracting and Indexing
    • Editorial Policies
    • Reprints and Permissions
    • Job Opportunities
    • Terms and Conditions
    • Contact
  • Journals
    • All Journals
    • Biomedical Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Experimental and Therapeutic Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Epigenetics
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Functional Nutrition
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Molecular Medicine
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • International Journal of Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Medicine International
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular and Clinical Oncology
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Molecular Medicine Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Letters
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • Oncology Reports
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
    • World Academy of Sciences Journal
      • Information for Authors
      • Editorial Policies
      • Editorial Board
      • Aims and Scope
      • Abstracting and Indexing
      • Bibliographic Information
      • Archive
  • Articles
  • Information
    • For Authors
    • For Reviewers
    • For Librarians
    • For Advertisers
    • Conferences
  • Language Editing
Login Register Submit
  • This site uses cookies
  • You can change your cookie settings at any time by following the instructions in our Cookie Policy. To find out more, you may read our Privacy Policy.

    I agree
Search articles by DOI, keyword, author or affiliation
Search
Advanced Search
presentation
Molecular Medicine Reports
Join Editorial Board Propose a Special Issue
Print ISSN: 1791-2997 Online ISSN: 1791-3004
Journal Cover
December-2020 Volume 22 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

Journals

International Journal of Molecular Medicine

International Journal of Molecular Medicine

International Journal of Molecular Medicine is an international journal devoted to molecular mechanisms of human disease.

International Journal of Oncology

International Journal of Oncology

International Journal of Oncology is an international journal devoted to oncology research and cancer treatment.

Molecular Medicine Reports

Molecular Medicine Reports

Covers molecular medicine topics such as pharmacology, pathology, genetics, neuroscience, infectious diseases, molecular cardiology, and molecular surgery.

Oncology Reports

Oncology Reports

Oncology Reports is an international journal devoted to fundamental and applied research in Oncology.

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine

Experimental and Therapeutic Medicine is an international journal devoted to laboratory and clinical medicine.

Oncology Letters

Oncology Letters

Oncology Letters is an international journal devoted to Experimental and Clinical Oncology.

Biomedical Reports

Biomedical Reports

Explores a wide range of biological and medical fields, including pharmacology, genetics, microbiology, neuroscience, and molecular cardiology.

Molecular and Clinical Oncology

Molecular and Clinical Oncology

International journal addressing all aspects of oncology research, from tumorigenesis and oncogenes to chemotherapy and metastasis.

World Academy of Sciences Journal

World Academy of Sciences Journal

Multidisciplinary open-access journal spanning biochemistry, genetics, neuroscience, environmental health, and synthetic biology.

International Journal of Functional Nutrition

International Journal of Functional Nutrition

Open-access journal combining biochemistry, pharmacology, immunology, and genetics to advance health through functional nutrition.

International Journal of Epigenetics

International Journal of Epigenetics

Publishes open-access research on using epigenetics to advance understanding and treatment of human disease.

Medicine International

Medicine International

An International Open Access Journal Devoted to General Medicine.

Journal Cover
December-2020 Volume 22 Issue 6

Full Size Image

Sign up for eToc alerts
Recommend to Library

  • Article
  • Citations
    • Cite This Article
    • Download Citation
    • Create Citation Alert
    • Remove Citation Alert
    • Cited By
  • Similar Articles
    • Related Articles (in Spandidos Publications)
    • Similar Articles (Google Scholar)
    • Similar Articles (PubMed)
  • Download PDF
  • Download XML
  • View XML
Article Open Access

Ameliorative effects and mechanism of crocetin in arsenic trioxide‑induced cardiotoxicity in rats

  • Authors:
    • Zhifeng Zhao
    • Jinghan Li
    • Bin Zheng
    • Yingran Liang
    • Jing Shi
    • Jianping Zhang
    • Xue Han
    • Li Chu
    • Xi Chu
    • Yonggang Gao
  • View Affiliations / Copyright

    Affiliations: Department of Pharmaceutics, School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, P.R. China, Department of Preventive Medicine, School of Basic Medicine, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, P.R. China, Department of Pharmaceutics, School of Pharmacy, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, P.R. China, Department of Pharmacy, The Fourth Hospital of Hebei Medical University, Shijiazhuang, Hebei 050011, P.R. China , Hebei Key Laboratory of Integrative Medicine on Liver‑Kidney Patterns, Hebei University of Chinese Medicine, Shijiazhuang, Hebei 050200, P.R. China
    Copyright: © Zhao et al. This is an open access article distributed under the terms of Creative Commons Attribution License.
  • Pages: 5271-5281
    |
    Published online on: October 14, 2020
       https://doi.org/10.3892/mmr.2020.11587
  • Expand metrics +
Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )
Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )
Cited By (CrossRef): 0 citations Loading Articles...

This article is mentioned in:



Abstract

Arsenic trioxide (ATO) is commonly used to treat patients with acute promyelocytic leukemia since it was authorized by the U.S. Food and Drug Administration in the 1970s, but its applicability has been limited by its cardiotoxic effects. Therefore, the aim of the present study was to investigate the cardioprotective effects and underlying mechanism of crocetin (CRT), the critical ingredient of saffron. Sprague‑Dawley rats were then randomly divided into four groups (n=10/group): i) Control group; ii) ATO group, iii) CRT‑low (20 mg/kg) group; and iv) CRT‑high (40 mg/kg) group. Rats in the Control and ATO groups were intraperitoneally injected with equal volumes of 0.9% sodium chloride solution, and CRT groups were administered with either 20 and 40 mg/kg CRT. Following 6 h, all groups except the Control group were intraperitoneally injected with 5 mg/kg ATO over 10 days. Cardiotoxicity was indicated by changes in electrocardiographic (ECG) patterns, morphology and marker enzymes. Histomorphological changes in the heart tissue were observed by pathological staining. The levels of superoxide dismutase, glutathione peroxidase, malondialdehyde and catalase in the serum were analyzed using colometric commercial assay kits, and the levels of reactive oxygen species in the heart tissue were detected using the fluorescent probe dihydroethidium. The expression levels of inflammatory factors and activities of apoptosis‑related proteins were analyzed using immunohistochemistry. The protein expression levels of silent information regulator of transcription 1 were measured using western blotting. Cardiotoxicity was induced in male Sprague‑Dawley rats with ATO (5 mg/kg). CRT (20 and 40 mg/kg) and ATO were co‑administered to evaluate possible cardioprotective effects. CRT significantly reduced the heart rate and J‑point elevation induced by ATO in rats. Histological changes were evaluated via hematoxylin and eosin staining. CRT decreased the levels of creatine kinase and lactate dehydrogenase, increased the activities of superoxide dismutase, glutathione‑peroxidase and catalase, and decreased the levels of malondialdehyde and reactive oxygen species. Moreover, CRT downregulated the expression levels of the pro‑inflammatory factors IL‑1, TNF‑α, IL‑6, Bax and p65, as well as increased the expression of Bcl‑2. It was also identified that CRT enhanced silent information regulator of transcription 1 protein expression. Thus, the present study demonstrated that CRT treatment effectively ameliorated ATO‑induced cardiotoxicity. The protective effects of CRT can be attributed to the inhibition of oxidative stress, inflammation and apoptosis. Therefore, CRT represents a promising therapeutic method for improving the cardiotoxic side effects caused by ATO treatment, and additional clinical applications are possible, but warrant further investigation.
View Figures

Figure 1

Figure 2

Figure 3

Figure 4

Figure 5

Figure 6

Figure 7

Figure 8

Figure 9

Figure 10

View References

1 

Rao Y, Li R and Zhang D: A drug from poison: How the therapeutic effect of arsenic trioxide on acute promyelocytic leukemia was discovered. Sci China Life Sci. 56:495–502. 2013.PubMed/NCBI

2 

Sfaxi I, Charradi K, Limam F, El May MV and Aouani E: Grape seed and skin extract protects against arsenic trioxide induced oxidative stress in rat heart. Can J Physiol Pharmacol. 94:168–176. 2016.PubMed/NCBI

3 

Yu X, Wang Z, Shu Z, Li Z, Ning Y, Yun K, Bai H, Liu R and Liu W: Effect and mechanism of Sorbus pohuashanensis (Hante) Hedl. Flavonoids protect against arsenic trioxide-induced cardiotoxicity. Biomed Pharmacother. 88:1–10. 2017.PubMed/NCBI

4 

Raghu KG and Cherian OL: Characterization of cytotoxicity induced by arsenic trioxide (a potent anti-APL drug) in rat cardiac myocytes. J Trace Elem Med Biol. 23:61–68. 2009.PubMed/NCBI

5 

Varghese MV, Abhilash M, Paul MV, Alex M and Nair RH: Omega-3 fatty acid protects against arsenic trioxide-induced cardiotoxicity in vitro and in vivo. Cardiovasc Toxicol. 17:109–119. 2017.PubMed/NCBI

6 

Manna P, Sinha M and Sil PC: Arsenic-induced oxidative myocardial injury: Protective role of arjunolic acid. Arch Toxicol. 82:137–149. 2008.PubMed/NCBI

7 

Zhang W, Guo C, Gao R, Ge M, Zhu Y and Zhang Z: The protective role of resveratrol against arsenic trioxide-induced cardiotoxicity. Evid Based Complement Alternat Med. 2013:4078392013.PubMed/NCBI

8 

Abeyrathna P and Su Y: The critical role of Akt in cardiovascular function. Vascul Pharmacol. 74:38–48. 2015.PubMed/NCBI

9 

Wang Z, Yu J, Wu J, Qi F, Wang H, Wang Z and Xu Z: Scutellarin protects cardiomyocyte ischemia-reperfusion injury by reducing apoptosis and oxidative stress. Life Sci. 157:200–207. 2016.PubMed/NCBI

10 

Galano A: Free radicals induced oxidative stress at a molecular level: The current status, challenges and perspectives of computational chemistry based protocols. J Mex Chem Soc. 59:231–262. 2015.

11 

Zhou SS, He F, Chen AH, Hao PY and Song XD: Suppression of rat frizzled-2 attenuates hypoxia/reoxygenation-induced Ca2+ accumulation in rat H9c2 cells. Exp Cell Res. 318:1480–1491. 2012.PubMed/NCBI

12 

Andrades ME, Ritter C and Dal-Pizzol F: The role of free radicals in sepsis development. Front Biosci (Elite Ed). 1:277–287. 2009.PubMed/NCBI

13 

Baird AM, OByrne KJ and Gray SG: Reactive oxygen species and reactive nitrogen species in epigenetic modifications. Biochem Soc Trans. 437–455. 2012.

14 

Edson KZ and Rettie AE: CYP4 enzymes as potential drug targets: Focus on enzyme multiplicity, inducers and inhibitors, and therapeutic modulation of 20-hydroxyeicosatetraenoic acid (20-HETE) synthase and fatty acid ω-hydroxylase activities. Curr Top Med Chem. 13:1429–1440. 2013.PubMed/NCBI

15 

Nakayama H, Chen X, Baines CP, Klevitsky R, Zhang X, Zhang H, Jaleel N, Chua BH, Hewett TE, Robbins J, et al: Ca2+- and Mitochondrial-dependent cardiomyocyte necrosis as a primary mediator of heart failure. J Clin Invest. 117:2431–2444. 2007.PubMed/NCBI

16 

Zhang J, Zhang Y, Wang W, Li C and Zhang Z: Double-sided personality: Effects of arsenic trioxide on inflammation. Inflammation. 41:1128–1134. 2018.PubMed/NCBI

17 

Gasparini C and Feldmann M: NF-κB as a target for modulating inflammatory responses. Curr Pharm Des. 18:5735–5745. 2012.PubMed/NCBI

18 

Li S, Wang Y, Zhao H, He Y and Xing M: NF-κB-mediated inflammation correlates with calcium overload under arsenic trioxide-induced myocardial damage in Gallus gallus. Chemosphere. 185:618–627. 2017.PubMed/NCBI

19 

Saad SY, Alkharfy KM and Arafah MM: Cardiotoxic effects of arsenic trioxide/imatinib mesilate combination in rats. J Pharm Pharmacol. 58:567–573. 2006.PubMed/NCBI

20 

Sepand MR, Razavi-Azarkhiavi K, Omidi A, Zirak MR, Sabzevari S, Kazemi AR and Sabzevari O: Effect of acetyl-l-carnitine on antioxidant status, lipid peroxidation, and oxidative damage of arsenic in rat. Biol Trace Elem Res. 171:107–115. 2016.PubMed/NCBI

21 

Miao X, Tang Z, Wang Y, Su G, Sun W, Wei W, Li W, Miao L, Cai L, Tan Y and Liu Q: Metallothionein prevention of arsenic trioxide-induced cardiac cell death is associated with its inhibition of Mitogen-activated protein kinases activation in vitro and in vivo. Toxicol Lett. 220:277–285. 2013.PubMed/NCBI

22 

Zhao X, Feng T, Chen H, Shan H, Zhang Y, Lu Y and Yang B: Arsenic trioxide-induced apoptosis in H9c2 cardiomyocytes: Implications in cardiotoxicity. Basic Clin Pharmacol Toxicol. 102:419–425. 2008.PubMed/NCBI

23 

Testai L, Piragine E, Piano I, Flori L and Calderone V: The citrus flavonoid naringenin protects the myocardium from ageing-dependent dysfunction: Potential role of SIRT1. Oxid Med Cell Longev. 2020:46502072020.PubMed/NCBI

24 

Pirola RC and Elmslie RG: Exchange transfusion and liver perfusion in the treatment of acute hepatic coma. Med J Aust. 1:891–894. 1968.PubMed/NCBI

25 

Mu W, Zhang Q, Tang X, Fu W, Zheng W, Lu Y, Li H, Wei Y, Li L, She Z, et al: Overexpression of a dominant-negative mutant of SIRT1 in mouse heart causes cardiomyocyte apoptosis and Early-onset heart failure. Sci China Life Sci. 57:915–924. 2014.PubMed/NCBI

26 

Zhang W, Li Y and Ge Z: Cardiaprotective effect of crocetin by attenuating apoptosis in isoproterenol induced myocardial infarction rat model. Biomed Pharmacother. 93:376–382. 2017.PubMed/NCBI

27 

Batarseh YS, Bharate SS, Kumar V, Kumar A, Vishwakarma RA, Bharate SB and Kaddoumi A: Crocus sativus extract tightens the Blood-brain barrier, reduces amyloid beta load and related toxicity in 5XFAD mice. ACS Chem Neurosci. 8:1756–1766. 2017.PubMed/NCBI

28 

Hosseinzadeh H, Sadeghnia HR, Ziaee T and Danaee A: Protective effect of aqueous saffron extract (Crocus sativus L.) and crocin, its active constituent, on renal ischemia-reperfusion-induced oxidative damage in rats. J Pharm Pharm Sci. 8:387–393. 2005.PubMed/NCBI

29 

Umigai N, Murakami K, Ulit MV, Antonio LS, Shirotori M, Morikawa H and Nakano T: The pharmacokinetic profile of crocetin in healthy adult human volunteers after a single oral administration. Phytomedicine. 18:575–578. 2011.PubMed/NCBI

30 

Gao K, Liu F, Chen X, Chen M, Deng Q, Zou X and Guo H: Crocetin protects against fulminant hepatic failure induced by lipopolysaccharide/D-galactosamine by decreasing apoptosis, inflammation and oxidative stress in a rat model. Exp Ther Med. 18:3775–3782. 2019.PubMed/NCBI

31 

Bolhassani A, Khavari A and Bathaie SZ: Saffron and natural carotenoids: Biochemical activities and anti-tumor effects. Biochim Biophys Acta. 1845:20–30. 2014.PubMed/NCBI

32 

Shen XC and Qian ZY: Effects of crocetin on antioxidant enzymatic activities in cardiac hypertrophy induced by norepinephrine in rats. Pharmazie. 61:348–352. 2006.PubMed/NCBI

33 

Yang L, Qian Z, Ji H, Yang R, Wang Y, Xi L, Sheng L, Zhao B and Zhang X: Inhibitory effect on protein kinase Ctheta by Crocetin attenuates palmitate-induced insulin insensitivity in 3T3-L1 adipocytes. Eur J Pharmacol. 642:47–55. 2010.PubMed/NCBI

34 

Diao SL, Sun JW, Ma BX, Li XM and Wang D: Influence of crocetin on high-cholesterol diet induced atherosclerosis in rats via anti-oxidant activity together with inhibition of inflammatory response and p38 MAPK signaling pathway. Saudi J Biol Sci. 25:493–499. 2018.PubMed/NCBI

35 

Mancini A, Serrano-Díaz J, Nava E, DAlessandro AM, Alonso GL, Carmona M and Llorens S: Crocetin, a carotenoid derived from saffron (Crocus sativus L.), improves acetylcholine-induced vascular relaxation in hypertension. J Vasc Res. 51:393–404. 2014.PubMed/NCBI

36 

Cai J, Yi FF, Bian ZY, Shen DF, Yang L, Yan L, Tang QZ, Yang XC and Li H: Crocetin protects against cardiac hypertrophy by blocking MEK-ERK1/2 signalling pathway. J Cell Mol Med. 13:909–925. 2009.PubMed/NCBI

37 

Shen XC and Qian ZY: Effect of crocetin on cardiac hypertrophy induced by overloading pressure in rats. Acta Pharm Sin. 39:172–175. 2004.

38 

Li CY, Huang WF, Wang QL, Wang F, Cai E, Hu B, Du JC, Wang J, Chen R, Cai XJ, et al: Crocetin induces cytotoxicity in colon cancer cells via p53-independent mechanisms. Asian Pac J Cancer Prev. 13:3757–3761. 2012.PubMed/NCBI

39 

Kim SH, Lee JM, Kim SC, Park CB and Lee PC: Proposed cytotoxic mechanisms of the saffron carotenoids crocin and crocetin on cancer cell lines. Biochem Cell Biol. 92:105–111. 2014.PubMed/NCBI

40 

Yang M, Mao G, Ouyang L, Shi C, Hu P and Huang S: Crocetin alleviates myocardial ischemia/reperfusion injury by regulating inflammation and the unfolded protein response. Mol Med Rep. 21:641–648. 2020.PubMed/NCBI

41 

Zhang D: Comparison of the effect of different anesthetics in five hundred rats. Lab Anim Sci. 1:19–20. 2007.

42 

Zhao H, Haitao LI, Dingwei GU, Suxin LI and Fang Y: Effects of oral spironolactone on TNF-α expression of myocardial tissues in spontaneous hypertension rats. Tianjin Med J. 40:64–66. 2012.

43 

Wang T, Sun X, Cui H, Liu K and Zhao J: The peptide compound urantide regulates collagen metabolism in atherosclerotic rat hearts and inhibits the JAK2/STAT3 pathway. Mol Med Rep. 21:1097–1106. 2020.PubMed/NCBI

44 

Knuckles TL, Buntz JG, Paffett M, Channell M, Harmon M, Cherng T, Lucas SN, McDonald JD, Kanagy NL and Campen MJ: Formation of vascular s-nitrosothiols and plasma nitrates/nitrites following inhalation of diesel emissions. J Toxicol Environ Health A. 74:828–837. 2011.PubMed/NCBI

45 

Song Q, Chu X, Zhang X, Bao Y, Zhang Y, Guo H, Liu Y, Liu H, Zhang J, Zhang Y and Chu L: Mechanisms underlying the cardioprotective effect of Salvianic acid A against isoproterenol-induced myocardial ischemia injury in rats: Possible involvement of L-type calcium channels and myocardial contractility. J Ethnopharmacol. 189:157–164. 2016.PubMed/NCBI

46 

Han X, Li M, Zhao Z, Zhang Y, Zhang J, Zhang X, Zhang Y, Guan S and Chu L: Mechanisms underlying the cardio-protection of total ginsenosides against myocardial ischemia in rats in vivo and in vitro: Possible involvement of L-type Ca2+ channels, contractility and Ca2+ homeostasis. J Pharmacol Sci. 139:240–248. 2019.PubMed/NCBI

47 

Lee T, Chen C and Chang N: Cardiac sympathetic hyperinnervation in deoxycorticosterone acetate-salt hypertensive rats. Clin Sci (Lond). 123:445–457. 2012.PubMed/NCBI

48 

Li R, Liu Y, Xie J, Huang X, Zhang L, Liu H and Li L: Sirt3 mediates the protective effect of hydrogen in inhibiting ROS-induced retinal senescence. Free Radic Biol Med. 135:116–124. 2019.PubMed/NCBI

49 

Jin W, Xue Y, Xue Y, Han X, Song Q, Zhang J, Li Z, Cheng J, Guan S, Sun S and Chu L: Tannic acid ameliorates arsenic Trioxide-induced nephrotoxicity, contribution of NF-κB and Nrf2 pathways. Biomed. Pharmacother. 126:1100472020.

50 

Meister AL, Doheny KK and Travagli RA: Necrotizing enterocolitis attenuates developmental heart rate variability increases in newborn rats. Neurogastroenterol Motil. 31:e134842019.PubMed/NCBI

51 

Jin W, Zhang Y, Xue Y, Han X, Zhang X, Ma Z, Sun S, Chu X, Cheng J, Guan S, et al: Crocin attenuates isoprenaline-induced myocardial fibrosis by targeting TLR4/NF-κB signaling: Connecting oxidative stress, inflammation, and apoptosis. Naunyn Schmiedebergs Arch Pharmacol. 393:13–23. 2020.PubMed/NCBI

52 

Chu L, Li P, Song T, Han X, Zhang X, Song Q, Liu T, Zhang Y and Zhang J: Protective effects of tannic acid on pressure overload-induced cardiac hypertrophy and underlying mechanisms in rats. J Pharm Pharmacol. 69:1191–1207. 2017.PubMed/NCBI

53 

Sun Q, Jia N, Wang W, Jin H, Xu J and Hu H: Activation of SIRT1 by curcumin blocks the neurotoxicity of amyloid-β 25–35 in rat cortical neurons. Biochem Biophys Res Commun. 448:89–94. 2014.PubMed/NCBI

54 

Tallman MS: Treatment of relapsed or refractory acute promyelocytic leukemia. Best Pract Res Clin Haematol. 20:57–65. 2007.PubMed/NCBI

55 

Sun TL, Liu Z, Qi ZJ, Huang YP, Gao XQ and Zhang YY: (−)-Epigallocatechin-3-gallate (EGCG) attenuates arsenic-induced cardiotoxicity in rats. Food Chem Toxicol. 93:102–110. 2016.PubMed/NCBI

56 

Hashemi M and Hosseinzadeh H: A comprehensive review on biological activities and toxicology of crocetin. Food Chem Toxicol. 130:44–60. 2019.PubMed/NCBI

57 

Liang X and Qian Z: Pharmacological properties of crocetin and crocin (digentiobiosyl ester of crocetin) from saffron. Nat Prod Commun. 1:65–75. 2006.

58 

Hosseini A, Razavi BM and Hosseinzadeh H: Pharmacokinetic properties of saffron and its active components. Eur J Drug Metab Pharmacokinet. 43:383–390. 2018.PubMed/NCBI

59 

Xi L, Qian Z, Du P and Fu J: Pharmacokinetic properties of crocin (crocetin digentiobiose ester) following oral administration in rats. Phytomedicine. 14:633–636. 2007.PubMed/NCBI

60 

Asai A, Nakano T, Takahashi M and Nagao A: Orally administered crocetin and crocins are absorbed into blood plasma as crocetin and its glucuronide conjugates in mice. J Agric Food Chem. 53:7302–7306. 2005.PubMed/NCBI

61 

Zhang Y, Fei F, Zhen L, Zhu X, Wang J, Li S, Geng J, Sun R, Yu X, Chen T, et al: Sensitive analysis and simultaneous assessment of pharmacokinetic properties of crocin and crocetin after oral administration in rats. J Chromatogr B Analyt Technol Biomed Life Sci. 1044-1045:1–7. 2017.PubMed/NCBI

62 

Farkhondeh T, Samarghandian S, Samini F and Sanati AR: Protective effects of crocetin on depression-like behavior induced by immobilization in rat. CNS Neurol Disord Drug Targets. 17:361–369. 2018.PubMed/NCBI

63 

Danesi R, Tacca MD and Soldani G: Measurement of the SαT segment as the most reliable electrocardiogram parameter for the assessment of adriamycin-induced cardiotoxicity in the rat. J Pharmacol Methods. 16:251–259. 1986.PubMed/NCBI

64 

Kumari P, Saifi MA, Khurana A and Godugu C: Cardioprotective effects of nanoceria in a murine model of cardiac remodeling. J Trace Elem Med Biol. 50:198–208. 2018.PubMed/NCBI

65 

Tang Y, Wang M, Le X, Meng J, Huang L, Yu P, Chen J and Wu P: Antioxidant and cardioprotective effects of Danshensu (3-(3, 4-dihydroxyphenyl)-2-hydroxy-propanoic acid from Salvia miltiorrhiza) on isoproterenol-induced myocardial hypertrophy in rats. Phytomedicine. 18:1024–1030. 2011.PubMed/NCBI

66 

Shan H, Zhang Y, Cai B, Chen X, Fan Y, Yang L, Chen X, Liang H, Zhang Y, Song X, et al: Upregulation of microRNA-1 and microRNA-133 contributes to arsenic-induced cardiac electrical remodeling. Int J Cardiol. 167:2798–2805. 2013.PubMed/NCBI

67 

Drolet B, Simard C and Roden DM: Unusual effects of a QT-prolonging drug, arsenic trioxide, on cardiac potassium currents. Circulation. 109:26–29. 2004.PubMed/NCBI

68 

Aposhian HV and Aposhian MM: Arsenic toxicology: Five questions. Chem Res Toxicol. 19:1–15. 2006.PubMed/NCBI

69 

Hwang JT, Kwon DY, Park OJ and Kim MS: Resveratrol protects ROS-induced cell death by activating AMPK in H9c2 cardiac muscle cells. Genes Nutr. 2:323–326. 2008.PubMed/NCBI

70 

Oudit GY, Trivieri MG, Khaper N, Husain T, Wilson GJ, Liu P, Sole MJ and Backx PH: Taurine supplementation reduces oxidative stress and improves cardiovascular function in an Iron-overload murine model. Circulation. 109:1877–1885. 2004.PubMed/NCBI

71 

Li SW, Sun X, He Y, Guo Y, Zhao HJ, Hou ZJ and Xing MW: Assessment of arsenic trioxide in the heart of Gallus gallus: Alterations of oxidative damage parameters, inflammatory cytokines, and cardiac enzymes. Environ Sci Pollut Res Int. 24:5781–5790. 2017.PubMed/NCBI

72 

Kowalczuk K and Stryjecka-Zimmer M: The influence of oxidative stress on the level of malondialdehyde (MDA) in different areas of the rabbit brain. Ann Univ Mariae Curie Sklodowska Med. 57:160–164. 2002.PubMed/NCBI

73 

Djordjevic A, Spasic S, Jovanovic-Galovic A, Djordjevic R and Grubor-Lajsic G: Oxidative stress in diabetic pregnancy: SOD, CAT and GSH-Px activity and lipid peroxidation products. J Matern Fetal Neonatal Med. 16:367–372. 2004.PubMed/NCBI

74 

Alexa ID and Jerca L: The role of oxidative stress in the etiology of Pre-eclampsia: Changes at the GSH and GSH-Px levels in normal pregnancy and pre-eclampsia. Rev Med Chir Soc Med Nat Iasi. 100:131–135. 1996.(In Romanian). PubMed/NCBI

75 

Espinosa J, Pérez JM, López-Olvera JR, Ráez-Bravo A, Cano-Manuel FJ, Fandos P, Soriguer RC, Granados JE and Romero D: Evaluation of oxidant/antioxidant balance in Iberian ibex (Capra pyrenaica) experimentally infested with Sarcoptes scabiei. Vet Parasitol. 242:63–70. 2017.PubMed/NCBI

76 

Yang R, Yang L, Shen X, Cheng W, Zhao B, Ali KH, Qian Z and Ji H: Suppression of NF-κB pathway by crocetin contributes to attenuation of lipopolysaccharide-induced acute lung injury in mice. Eur J Pharmacol. 674:391–396. 2012.PubMed/NCBI

77 

Wang Y, Yu W, Shi C and Hu P: Crocetin attenuates sepsis-induced cardiac dysfunction regulation of inflammatory response and mitochondrial function. Front Physiol. 11:5142020.PubMed/NCBI

78 

Song L, Kang C, Sun Y, Huang WR, Liu W and Qian ZY: Crocetin inhibits lipopolysaccharide-induced inflammatory response in human umbilical vein endothelial cells. Cell Physiol Biochem. 40:443–452. 2016.PubMed/NCBI

79 

Mantawy EM, El-Bakly WM, Esmat A, Badr AM and El-Demerdash E: Chrysin alleviates acute doxorubicin cardiotoxicity in rats via suppression of oxidative stress, inflammation and apoptosis. Eur J Pharmacol. 728:107–118. 2014.PubMed/NCBI

80 

Liu MH, Shan J, Li J, Zhang Y and Lin XL: Resveratrol inhibits Doxorubicin-induced cardiotoxicity via sirtuin 1 activation in H9c2 cardiomyocytes. Exp Ther Med. 12:1113–1118. 2016.PubMed/NCBI

81 

Sun Z, Lu W, Lin N, Lin H, Zhang J, Ni T, Meng L, Zhang C and Guo H: Dihydromyricetin alleviates doxorubicin-induced cardiotoxicity by inhibiting NLRP3 inflammasome through activation of SIRT1. Biochem Pharmacol. 175:1138882020.PubMed/NCBI

82 

Binu P, Priya N, Abhilash S, Vineetha R and Nair R: Studies on curative efficacy of monoterpene eugenol on anti-leukemic drug arsenic trioxide induced cardiotoxicity. Biomed Pharmacother. 91:559–566. 2017.PubMed/NCBI

Related Articles

  • Abstract
  • View
  • Download
  • Twitter
Copy and paste a formatted citation
Spandidos Publications style
Zhao Z, Li J, Zheng B, Liang Y, Shi J, Zhang J, Han X, Chu L, Chu X, Gao Y, Gao Y, et al: Ameliorative effects and mechanism of crocetin in arsenic trioxide‑induced cardiotoxicity in rats. Mol Med Rep 22: 5271-5281, 2020.
APA
Zhao, Z., Li, J., Zheng, B., Liang, Y., Shi, J., Zhang, J. ... Gao, Y. (2020). Ameliorative effects and mechanism of crocetin in arsenic trioxide‑induced cardiotoxicity in rats. Molecular Medicine Reports, 22, 5271-5281. https://doi.org/10.3892/mmr.2020.11587
MLA
Zhao, Z., Li, J., Zheng, B., Liang, Y., Shi, J., Zhang, J., Han, X., Chu, L., Chu, X., Gao, Y."Ameliorative effects and mechanism of crocetin in arsenic trioxide‑induced cardiotoxicity in rats". Molecular Medicine Reports 22.6 (2020): 5271-5281.
Chicago
Zhao, Z., Li, J., Zheng, B., Liang, Y., Shi, J., Zhang, J., Han, X., Chu, L., Chu, X., Gao, Y."Ameliorative effects and mechanism of crocetin in arsenic trioxide‑induced cardiotoxicity in rats". Molecular Medicine Reports 22, no. 6 (2020): 5271-5281. https://doi.org/10.3892/mmr.2020.11587
Copy and paste a formatted citation
x
Spandidos Publications style
Zhao Z, Li J, Zheng B, Liang Y, Shi J, Zhang J, Han X, Chu L, Chu X, Gao Y, Gao Y, et al: Ameliorative effects and mechanism of crocetin in arsenic trioxide‑induced cardiotoxicity in rats. Mol Med Rep 22: 5271-5281, 2020.
APA
Zhao, Z., Li, J., Zheng, B., Liang, Y., Shi, J., Zhang, J. ... Gao, Y. (2020). Ameliorative effects and mechanism of crocetin in arsenic trioxide‑induced cardiotoxicity in rats. Molecular Medicine Reports, 22, 5271-5281. https://doi.org/10.3892/mmr.2020.11587
MLA
Zhao, Z., Li, J., Zheng, B., Liang, Y., Shi, J., Zhang, J., Han, X., Chu, L., Chu, X., Gao, Y."Ameliorative effects and mechanism of crocetin in arsenic trioxide‑induced cardiotoxicity in rats". Molecular Medicine Reports 22.6 (2020): 5271-5281.
Chicago
Zhao, Z., Li, J., Zheng, B., Liang, Y., Shi, J., Zhang, J., Han, X., Chu, L., Chu, X., Gao, Y."Ameliorative effects and mechanism of crocetin in arsenic trioxide‑induced cardiotoxicity in rats". Molecular Medicine Reports 22, no. 6 (2020): 5271-5281. https://doi.org/10.3892/mmr.2020.11587
Follow us
  • Twitter
  • LinkedIn
  • Facebook
About
  • Spandidos Publications
  • Careers
  • Cookie Policy
  • Privacy Policy
How can we help?
  • Help
  • Live Chat
  • Contact
  • Email to our Support Team